SRRK

NASDAQ 已收盘

Scholar Rock Holding Corporation

47.79 USD
-1.45+4.23%
盘后 46.93 +2.36%
2026-08-03
市值
$5.73B
市盈率
EPS
-3.43
股息率
52 周区间
27.07 – 58.49
成交量
767.36K
Beta
0.68
目标价
59.31
52W 低 27.0752W 高 58.49
价格走势

公司简介

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company’s novel understanding of the molecular mechanisms of growth factor activation within the transforming growth factor beta (TGFβ) superfamily has enabled the development of a proprietary platform. This platform is used for the development of monoclonal antibodies that locally and selectively target the precursor, or laten...